|
HK1247089A1
(zh)
|
2015-03-10 |
2018-09-21 |
Aduro Biotech, Inc. |
用於活化“干扰素基因刺激物”依赖性信号传导的组合物和方法
|
|
GEP20207182B
(en)
|
2015-08-13 |
2020-11-25 |
Merck Sharp & Dohme |
Cyclic di-nucleotide compounds as sting agonists
|
|
US11453697B1
(en)
|
2015-08-13 |
2022-09-27 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
|
SMT202500412T1
(it)
*
|
2016-01-11 |
2025-11-10 |
Innate Tumor Immunity Inc |
Dinucleotidi ciclici per il trattamento di condizioni associate all’attività di sting quali il cancro
|
|
CN114751950B
(zh)
|
2016-03-18 |
2025-04-18 |
免疫传感器公司 |
环二核苷酸化合物及使用方法
|
|
US11098077B2
(en)
|
2016-07-05 |
2021-08-24 |
Chinook Therapeutics, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
|
EP3481402A4
(en)
|
2016-07-06 |
2020-01-22 |
Sperovie Biosciences, Inc. |
CONNECTIONS, COMPOSITIONS AND METHODS FOR TREATING A DISEASE
|
|
BR112019004042A2
(pt)
|
2016-08-30 |
2019-05-28 |
Dana-Farber Cancer Institute, Inc. |
composições de liberação de fármaco e usos das mesmas
|
|
TN2020000158A1
(en)
|
2016-10-04 |
2022-04-04 |
Merck Sharp & Dohme |
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
|
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
|
US20200055883A1
(en)
|
2017-02-17 |
2020-02-20 |
Eisai R&D Management Co., Ltd. |
Cyclic di-nucleotides derivative for the treatment of cancer
|
|
CN118267470A
(zh)
|
2017-04-13 |
2024-07-02 |
赛罗帕私人有限公司 |
抗SIRPα抗体
|
|
WO2018208667A1
(en)
|
2017-05-12 |
2018-11-15 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
|
US11259980B2
(en)
|
2017-07-31 |
2022-03-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Soft inflatable exosuit for knee rehabilitation
|
|
JP2020529421A
(ja)
|
2017-08-04 |
2020-10-08 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
がんの処置のためのＰＤ−１アンタゴニストおよびベンゾ［ｂ］チオフェンＳＴＩＮＧアゴニストの組み合わせ
|
|
CA3071538A1
(en)
|
2017-08-04 |
2019-02-07 |
Merck Sharp & Dohme Corp. |
Benzo[b]thiophene sting agonists for cancer treatment
|
|
MX2020002303A
(es)
|
2017-08-30 |
2020-09-10 |
Beijing Xuanyi Pharmasciences Co Ltd |
Dinucleotidos ciclicos como moduladores del estimulador de genes de interferon.
|
|
WO2019046511A1
(en)
|
2017-08-31 |
2019-03-07 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
|
|
US11667663B2
(en)
*
|
2017-08-31 |
2023-06-06 |
Bristol-Myers Squibb Company |
Cyclic dinucleotides as anticancer agents
|
|
WO2019051489A1
(en)
|
2017-09-11 |
2019-03-14 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
|
|
WO2019051488A1
(en)
|
2017-09-11 |
2019-03-14 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
|
|
JP7478660B2
(ja)
*
|
2017-09-14 |
2024-05-07 |
ヤンセン バイオファーマ インク． |
修飾ヌクレオシドホスホロアミダイト
|
|
US11660311B2
(en)
*
|
2017-10-10 |
2023-05-30 |
Bristol-Myers Squibb Company |
Cyclic dinucleotides as anticancer agents
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
PE20210156A1
(es)
|
2017-11-10 |
2021-01-26 |
Takeda Pharmaceuticals Co |
Compuestos moduladores de sting y metodos de elaboracion y uso
|
|
WO2019123339A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
US11685761B2
(en)
|
2017-12-20 |
2023-06-27 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
|
WO2019123340A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
EP3505527A1
(en)
*
|
2017-12-29 |
2019-07-03 |
Invivogen |
Cyclic dinucleotides for cytokine induction
|
|
US10519187B2
(en)
*
|
2018-02-13 |
2019-12-31 |
Bristol-Myers Squibb Company |
Cyclic dinucleotides as anticancer agents
|
|
ES2980374T3
(es)
*
|
2018-03-08 |
2024-10-01 |
Bristol Myers Squibb Co |
Dinucleótidos cíclicos como agentes anticancerosos
|
|
JP7337086B2
(ja)
|
2018-03-23 |
2023-09-01 |
武田薬品工業株式会社 |
スルファメート結合を有するｓｔｉｎｇモジュレーター化合物、及び製造及び使用の方法
|
|
US10793557B2
(en)
|
2018-04-03 |
2020-10-06 |
Merck Sharp & Dohme Corp. |
Sting agonist compounds
|
|
US11702430B2
(en)
|
2018-04-03 |
2023-07-18 |
Merck Sharp & Dohme Llc |
Aza-benzothiophene compounds as STING agonists
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
MA52754A
(fr)
|
2018-05-25 |
2021-04-14 |
Incyte Corp |
Composés hétérocycliques tricycliques en tant qu'activateurs de sting
|
|
EP3820477A4
(en)
|
2018-07-10 |
2022-07-13 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES
|
|
TW202030199A
(zh)
*
|
2018-07-17 |
2020-08-16 |
美商健生生物科技公司 |
作為ｓｔｉｎｇ促效劑之環狀二核苷酸
|
|
US10875872B2
(en)
|
2018-07-31 |
2020-12-29 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
|
WO2020028565A1
(en)
|
2018-07-31 |
2020-02-06 |
Incyte Corporation |
Tricyclic heteraryl compounds as sting activators
|
|
KR102783784B1
(ko)
|
2018-08-16 |
2025-03-21 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
화합물의 염 및 이의 결정
|
|
SMT202500141T1
(it)
|
2018-09-06 |
2025-05-12 |
Daiichi Sankyo Co Ltd |
Coniugati farmaco-anticorpo di derivati dinucleotidici ciclici
|
|
US20200113912A1
(en)
|
2018-09-12 |
2020-04-16 |
Silverback Therapeutics, Inc. |
Methods and Compositions for the Treatment of Disease with Immune Stimulatory Conjugates
|
|
MX2021003207A
(es)
|
2018-09-21 |
2021-06-23 |
Shanghai De Novo Pharmatech Co Ltd |
Analogo de dinucleotido ciclico. composicion farmaceutica del mismo y su aplicacion.
|
|
US11110106B2
(en)
|
2018-10-29 |
2021-09-07 |
Venenum Biodesign, LLC |
Sting agonists for treating bladder cancer and solid tumors
|
|
AU2019371206A1
(en)
|
2018-10-29 |
2021-05-27 |
Venenum Biodesign, LLC |
Novel sting agonists
|
|
WO2020089815A1
(en)
|
2018-10-31 |
2020-05-07 |
Novartis Ag |
Antibody conjugates comprising sting agonist
|
|
US11596692B1
(en)
|
2018-11-21 |
2023-03-07 |
Incyte Corporation |
PD-L1/STING conjugates and methods of use
|
|
BR112021010466A2
(pt)
*
|
2018-12-04 |
2021-08-24 |
Bristol-Myers Squibb Company |
Processo para a preparação de um dinucleotídeo cíclico
|
|
US12129267B2
(en)
|
2019-01-07 |
2024-10-29 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
|
WO2020163415A1
(en)
*
|
2019-02-05 |
2020-08-13 |
Bristol-Myers Squibb Company |
Synthesis of 1,2,5-tri-0-benz0yl-3-dibenzylamin0-3-de0xyrib0se as intermediate for producing 3'-amino-3'-deoxyadenosine and 3'-amino-3'-deoxyguanosine and the protected derivatives thereof
|
|
CN119770674A
(zh)
|
2019-05-10 |
2025-04-08 |
武田药品工业株式会社 |
抗体药物缀合物
|
|
WO2021007160A1
(en)
|
2019-07-05 |
2021-01-14 |
Tambo, Inc. |
Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy
|
|
TW202114710A
(zh)
*
|
2019-07-25 |
2021-04-16 |
英屬開曼群島商百濟神州有限公司 |
作為sting促效劑之環狀二核苷酸
|
|
WO2021067644A1
(en)
|
2019-10-01 |
2021-04-08 |
Silverback Therapeutics, Inc. |
Combination therapy with immune stimulatory conjugates
|
|
WO2021132589A1
(ja)
|
2019-12-26 |
2021-07-01 |
国立大学法人東海国立大学機構 |
ポリヌクレオチド及び医薬組成物
|
|
EP4106819A1
(en)
|
2020-02-21 |
2022-12-28 |
Silverback Therapeutics, Inc. |
Nectin-4 antibody conjugates and uses thereof
|
|
EP4115909A4
(en)
|
2020-03-06 |
2024-10-30 |
Daiichi Sankyo Company, Limited |
ANTIBODY-DRUG CONJUGATE WITH NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE
|
|
EP4134098A4
(en)
|
2020-04-10 |
2024-05-15 |
ONO Pharmaceutical Co., Ltd. |
Method of cancer therapy
|
|
US20230158057A1
(en)
*
|
2020-04-21 |
2023-05-25 |
Duke University |
Compositions and methods for the treatment of pain
|
|
CA3178252A1
(en)
|
2020-05-11 |
2021-11-18 |
Erytech Pharma |
Red cell extracellular vesicles (rcevs) containing cargoes and methods of use and production thereof
|
|
KR20230047361A
(ko)
|
2020-07-01 |
2023-04-07 |
아르스 파마슈티컬스 인크. |
항-asgr1 항체 접합체 및 이의 용도
|
|
JP2023537066A
(ja)
|
2020-08-07 |
2023-08-30 |
タンボ・インコーポレイテッド |
トランス－シクロオクテン生体直交型薬剤並びに癌及び免疫療法における使用
|
|
TW202227479A
(zh)
|
2020-09-02 |
2022-07-16 |
日商第一三共股份有限公司 |
新穎內－β－Ｎ－乙醯葡萄糖胺苷酶
|
|
EP4228657A4
(en)
*
|
2020-10-15 |
2024-11-20 |
The Regents Of The University Of Michigan |
Crystalline polymorphic forms of sting agonists associated with metal ions capable of modulating an immune response
|
|
KR102466750B1
(ko)
*
|
2020-10-23 |
2022-11-15 |
아주대학교산학협력단 |
인돌리진 유도체를 유효성분으로 포함하는 인터페론 유전자 자극제 조성물
|
|
JP2023548310A
(ja)
|
2020-10-30 |
2023-11-16 |
アバクタ・ライフ・サイエンシーズ・リミテッド |
Ｆａｐ活性化血清半減期延長型治療用コンジュゲート
|
|
EP4240488A1
(en)
|
2020-11-09 |
2023-09-13 |
Takeda Pharmaceutical Company Limited |
Antibody drug conjugates
|
|
WO2023277168A1
(ja)
|
2021-06-30 |
2023-01-05 |
協和キリン株式会社 |
ポリヌクレオチド及び医薬組成物
|
|
KR20240155298A
(ko)
|
2022-03-02 |
2024-10-28 |
다이이찌 산쿄 가부시키가이샤 |
Fc 함유 분자의 제조 방법
|
|
WO2024048490A1
(ja)
|
2022-08-29 |
2024-03-07 |
第一三共株式会社 |
変異Ｆｃ領域を含む抗体薬物コンジュゲート
|